Stryker Corporation to Acquire Invuity

(San Francisco, CA, USA), to acquire all of its outstanding shares for USD 7.40 per share in cash, implying a total equity value of approximately USD 190 million.

Invuity is a medical technology company focused on advanced surgical devices to enable better visualization. It offers advanced photonics and single-use, lighted instruments that deliver enhanced visualization for a wide variety of clinical applications, including orthopedic and spine surgery, general surgery, and women's health procedures, and has recently entered the enhanced energy market. Stryker is a medical technology company that offers products and services in orthopedics, medical and surgical, and neurotechnology and spine that help improve patient and hospital outcomes. Invuity's portfolio of products is highly complementary to the surgical portfolio of Stryker's Instruments business.

"Invuity's innovative products in the single-use lighted instrumentation and enhanced energy markets provide best in class illumination and help make surgery safer," said Spencer S. Stiles, Group President, Neurotechnology, Instruments and Spine. "I look forward to the work we will do together to advance Stryker's mission of making healthcare better."